grafts usually recover from the stress of the operation quickly and uneventfully, and can be discharged within one or 2 days from the intensive care unit (leU). In contrast, there is extreme morbidity and mortality in patients whose new livers do not resume function promptly, whose grafts fail secondarily because of rejection or technical accidents, and whose grafts are sec. ondarily damaged after renal or cardiopulmonary complications (9) . Accurate prediction of the fate of these hepatic grafts is an important objective.
The Hannover liver group proposed the metabolic assessment of transplanted liver allografts with AKBR as a parameter (10, 11) . They showed that an AKBR below 0.7 at 24 hr after organ recirculation was an early predictor of graft failure, but did not provide information beyond the first day. In the present study, the redox potential of the liver allografts was monitored with AKBR during the operation and daily until the patient was discharged from the ICU, died, or underwent retransplantation. A close relationship between the ultimate graft function and the changes in the AKBR within 2 postoperative days could be documented. This information should be helpful in making early decisions in future cases about the need for retransplantation.
MATERIALS AND METHODS
Between Septembef 9, 1989 and Decembef 13, 1989 ,81 adult patients were studied after 87 orthotopic liver transplantations (OL Tx). Two patients who died of strokes in the immediate postoperative period and one who died of cytomegalovirus pneumonia on the 29th postoperative day were excluded from the analysis_ Thia left 84 OL TJ in 78 patients for analysis. There were 42 males and 36 females, with ages ranging between 16 and 66 years (mean±SEM: 4S.7±L4l. Their diverse ofiginsl diseases are summarized in Table 1 . The degree of iIlnesa of each patient was defined prospectively by the criteria for urgency used by the 6-tier United Network for O",an Sharing (UN OS) distribution system (12) .
Seven of ~ 78 patients had a diagnosis of diabetes mellitus before operation_ Four were insulin·dependent and another 3 were on oral hypoglycemic qents for control of blood sugar. An additional 5 patients also required insulin during the immediate postoperative period. and in the data ltnltification these were classified as diabetic.
TrtJTl8plDnl procedures_ All donor procurements were with in situ infusion techniques (13) . The liven were preserved for 12.9±O.68 (mean ± SEM) br with Univenity of Wisconsin solution. HLA typing and cytotoxic antibody croumatch was performed but did not influence case selection .mce the results were not known until later. The anhepatic phase _ defined as the interval between the interruption of the recipient'. hepatic circulation and the reatoration of portal or arterial circulation to the graft. Throughout the operation, inciudiJ\( the an· • Six of these transplantations were after primary transplantation that failed during the time of study. The other 9 were for graft failure foUowing transplantation in an earlier year in patients whose primary course was not studied.
hepatic phase, serum lactate, blood glucose. and blood gases were measured at frequent intervals.
ImmuTI08uppression and rejection. Sixty-eight of the 8-l crafts (in· cluding retransplantations) were under treatment with FK506. to which a rapidly tapering course of prednisone was added, usually starting with 200 mg on the fmt day, and ending with 20 mg on the sixth day. The other 16 transplantations were done with limilar management but with cyc1osporine instead of FK506, and azathioprine in addition if there was a peripheral WBC >4000/mm'. In 2 patients. a course of OKT3 was started within the first 7 days because of suspicion of accelerated rejection, and in 9 patients whose grafts failed to function promptly one or more treatments with hemodialysis or continuous venovenous hemofiltration were given in the hope that antibodies or some other undetected harmful substance could be remo\-ed,
The AKBR was measured within 40 min by the enzymatic method using a Ketorex kit (Sanwa Chemical Company. LTD. Nagoya, Japan) and a KETO·340 semiautomatic spectrophotometer IIhara·denshi Company, LTD, Kasugai, Japan) (14, 15) . Four milliliurs of arterial blood was withdrawn before the portal vein wu undamped, at 6, 12 , and 24 hr after organ reperfusion, and once a day thereafter until the patient was discharged from the ICU, or died. No hypociycemia was encountered at the time of the AKBR measurement. The management of the patients in the ICU was performed independently of the AKBR measurement.
Stotistical analyses. Statistical analyses were baaed on analysis of variance and the t taL A P value less than 0.05 was regarded as significant. Values are expreased ss the mean ± SEM. Receiver operatinl characteristic curve analyses were applied to comparison of various clinical parametel1l and AKBR.
RESULTS
Of the 78 patients, 70 (89.7%) are alive. Survival was markedly influenced by the original diagnosis, with the poorest results being in patients with cirrhosis and in those undergoing retranspiantation after the first graft had been lost (or unexplained reasons (Table 1) . These latter patients have been called "liver-eaters." The following analyses are of graft survival.
Overall graft survil,,'Cll. In 66 (78.6%) of the 84 transplantations, the patients were discharged from the ICU in satisfactory condition within one month. These procedures were designated group A (successful graft). After 5 (6.0%) transplantations, the patienta were still on the ICU at the end of the first month. Their procedures were consigned to group B (compromised graft). Another 13 (15.4%) operations constituted group C (failed graft). Five of these recipients underwent retransplantation. Table 2 shows the clinical features in the 5 compromised graft cases of group B. Patient 1 was undergoing retransplan' tation because of primary graft nonfunction 2 days after the first OLTx. All of the patients were classified as classes 4-6 by the United Network for Organ Sharing. Class 5 patients are ICU·bound and class 6 patients are life support-dependent. All 5 required hemodialysis and/or mechanical respiratory assist postoperatively and all but one (case 2) had progressive in· creases in bilirubin levels. Patient 3 survived the study period but ultimately underwent retransplantation on the 46th post· operative day.
In group C, graft death occurred, with a mean interval of 11.4±2.9 days ( Table 3) . Specimens of eleven grafts were ex· amined by a pathologist during either the re-OL Tx or at autopsy. In the other cases in which an autopsy was denied, the final diagnosis of the graft was made based on the clinical events, premortem hepatic biopsies, and infectious disease data. The majority of the failed grafts had necrosis or severe ischemic injury. Five were lost from death or retransplantation after 1-4 days. Ischemic injury "."jth the supervention of sepsis led more slowly to the same result in the other 7 after 12 days. Sepsis was thought to have caused delayed hepatic failure in 4 of these patients. Humoral or cellular rejection was the primary diagnosis in patients who became septic secondarily.
Graft viability and AKBR. The AKBR was significantly suppressed in groups B and C as compared with group A, suggesting a close correlation between the redox state of the mitochondria of the transplanted graft in the early postoperative days and graft survival (P<O.OI) (Fig. 1 ). Because the ATP synthesizing ability of the liver mitochondria is closely related to the insulin level (16) , the changes in the AKBR after OL Tx were measured in diabetic and nondiabetic patients. In 12 diabetic patients in group A the AKBR was significantly suppressed as compared with that in the 54 nondiabetic patients up to the third post· operative day (Fig. 2) . Afterv.·ards the AKBR increased as insulin need decreased or with stabilization of insulin require· ments.
Among the 54 nondiabetic cases in group A, 24 were successfully discharged from the ICU within 2 days. The AKBRs in the morning of the day of discharge from the leu are shown in Figure 3 . All were ahove 1.05.
AKBR in nondiabetics.
Because of the confounding factor of insulin therapy, a separate analysis was performed of AKBR after culling 12 diabetic patients in group A and one diabetic patient in group C. For this analysis, the following stratification was used: state I, AKBRi:l.O; state II, 0.7-1.0; state III,
AKBR<0.7.
Group A: In 52 (96.3%) of 54 nondiabetic patients, the AKBR was elevated in state 1 by 2 days, and in 11 of these state I had already been reached within 24 hr. In the 2 exceptional cases (3.7%) the ratio was restored to state I by the 5th postoperative day.
Group B: In all 5 cases, the AKBR remained in state II • The criteria for urgency using for the UNOS distribution Iystem: Class 4, hospitAl-bound, not in intensive care unit (lCU); Clus 5, ICUbound, not ventilator-dependent; Class 6, in ICU, on ventilator, and often unconscious.
• PNC: postnecrotic cirrhosis: PSC-C: cryptogenic; PNC-E: ethanol; PNC-B: hepatitis B; CVVH: continuous venovenous hemofiltration. 'Total bilirubin level increased progressively more than 10 mg/d! or the pre-OL Tx level. • Primary nonfunctioning graft. Figure 4 shows the eventual changes in the AKBR of these 5 patients. Their AKBR fluctuated with a relatively high amplitude during their stay in the ICU, but never maintained normal levels (state I). Group C: In 7 of 12 cases the AKBR remained in state II for the first two postoperative days and gradually decreased to state III (Fig. 5) . Five of the 7 cases died and two underwent re-OL Tx. In one patient, the AKBR was in state I after one day but declined to state II (0.71) by the second postoperative day (Fig. 5) . This patient underwent re-OL Tx .-ith the diagnosis of accelerated acute rejection made from surgical specimen. In another 4 patients, the AKBR remained in state III without fluctuation (Fig. 6 ). All patients were in critical condition. Two of the 4 patients underwent re-OLTx and the other 2 patients died Figure 7 shows a schematic representation of the above resulta in nondiabetic patients, correlated with the outcome of OLTx. When the AKBR was restored to above 1.0 within 2 days after OL Tx, all grafts resumed satisfactory initial function_ When the AKBR was suppressed below 0.7 'state III) for longer than 24 hr after OLTx, no grafts survived. When the AKBR was between 0.7 and 1.0 (state II) for two days after ASONUMA ET AI.. OLTx. 50% of the grafts failed and 36% of the grafts were compromised (i.e., succeeded. although with a prolonged recovery).
In 2 exceptional patients in group A the AKBR decreased rapidly after it first rose to state I on the first day. The cause of the rapid decrease could have been acute rejection, an unrecognized technical error, or inappropriate postoperative care. Figure 8 shows how acute rejection can effect AKBR at a later time. A 51-year-old woman suffering from hemocromatosis had an AKBR of 1.5 on the first and second postoperative days but it decreased below 1.0 as the bilirubin began to rise on the third postoperative day. Therapy with cyclosporine was replaced with FK506 5 days after transplantation. The AKBR increased to 1.5 of normal levels, concomitant with normalization of the bilirubin level.
Various clinical parameters and AKBR. Table 4 shows the changes in the levels of lactate, total bilirubin. GOT. GPT. and PT in each group. The levels of total bilirubin on the first and second postoperative days were significantly increased in groups Band C as compared with those in group A (P<O.OO5). The levels of GOT and GPT on the first and second postoperative days were significantly increased in group C as compared with those in groups A and B. The levels of lactate at the end of operation and PT on the rll' St operative day were significantly increased in group C as compared with those in group A. These conventional liver function tests were shown to be inaccurate in discriminating between group A and group C, however, when compared with AKBR by receiver operating characteristic curve analysis (Figs. 9 and 10) .
AKBR in primary and retranspliJnt cases. Of the 84 grafts whose function was studied here, 69 were primary and the other 15 were retransplantations. In 6 of 15 retransplantations. both the primary and secondary graftings were followed with AKBR testing. In the other 9 cases, the primary grafting had been done before this study, and only the second liver could be studied. The first grafts were lost later for a variety of reasons. and after retransplantation the AKBR had decreased more ...
Postoperative Day than with primary grafting (Fig. 11) . This observation emphasized the greater risk of graft failure born by patients undergoing retransplantation after the failure of a first graft_ DISCUSSION It is documented that a reduced redox state of hepatic mitochondria indicating the accumulated intramitochondrial NADH, inhibits the activity of citrate synthase. which controls the turnover rate of the Krebs cycle, and the activity of pyruvate dehydrogenase. which controls the reaction from pyruvate to acetyl CoA. These result in a fall in the ATP-synthesizing ability of the liver mitochondria. With the depletion of ATP, many biological reactions cease in the hepatocytes, and biological membranes start to malfunction. There is considerable evidence to show that the AKBR is correlated closely with hepatic functions, not only in the case of primary hepatic disease but also in hemorrhagic shock, hypoxia, hemodilution, and multiple organ failure. As a result, the redox theory is gradually receiving wider acceptance among investigators, and the assessment of hepatic function according to AKBR has begun to be adopted in the medical field.
Because it has been suggested that the mitochondrial function is a powerful predictor of the outcome of hepatic surgery (3, 4) , it was natural to apply the AKBR testing in liver transplantation. In the present study a close correlation of the redox state of the graft mitochondria with graft survival was clearly demonstrated. During the anhepatic state, a rapid decrease in the AKBR occurred that was promptly returned toward normal by a well-functioning graft. This restoration did not occur if the liver had been damaged by events in the donor death, poor procurement or preservation, or performance of a flawed recipient operation. E~'en with a good liver, the AKBR could secondarily fail as early as 2 days after an initial increase. This may be due to accelerated rejection or other unidentified recipient factors.
The AKBR test is discriminating of liver quality, but it does not determine the etiology of the dysfunction. Taki et aI. (10, 11) reported that the cut-off below which recovery could not be expected after liver transplantation was 0.7 when the determination was made after 24 hr_ After liver transplantation, the restoration and maintenance of a high AKBR depends upon -Group A versus group a, P < 0.005.
'Group A versus group C, P < 0.01. I GroUP A versus group C, P < O.ooS.
'Group a versus group C, P < 0.05.
'Group B versus C, P < O.ooS.
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O~ 0" several factors: (1) recipient condition, (2) the viability of the donor liver, (3) the degree of intraoperative stress caused by anesthesia, transfusions, and transplantation techniques, (4) proper general postoperative care, and (5) harmful immune events including rejection. If the AKBR decreases, the cause is probably the failure to adequately meet one or more of these requirements. Which one(s) may be difficult to identify, but a signal can be obtained within 24 to 48 hr that retransplantation will be necessary. If the AKBR is less than 0.7 in a nondiabetic patient, the graft is hopeless. Even with AKBR l~'els of 0.7 to 1.0 in nondiabetic patients, the option of retransplantation should be considered seriously. Conversely, the achievement of an AKBR of 1.0 or better should discourage a decision for retransplantation in spite of anxiety for other reasons about graft viability.
Unfortunately, the road map is not so clear in patients who are temporarily or chronically diabetic, and in whom a reduced AKBR does not have the same prognostic significance. In this population, most of the AKBR levels were suboptimal, but this was not a uniformly ominous finding.
It is known that the mitochondrial response to hepatectomy is suppressed in diabetic rats and that insulin is regarded as the primary factor governing the changes in the mitochondrial metabolism (16) (17) (18) . It also has been shown the liver mitochondria are oxidized (the AKBR is increased) concomitant with a rise in serum insulin levels (19) . Finally, apart from a ;; a:
,. specific effect on the mitochondria, insulin has I proven influence on other measures of hepatocyte structure. :'mction, and the capacity for regeneration and repair (20, 2] '. These effects have been termed Whepatotrophic." Although f.:.her investigations are needed. it is already clear that insu:':': administration via an adequate route in "diabetic" patier::l could be of the utmost importance in postoperative man~"'!:nent. Other supponive care should include parenteral nutri:;,."tl. including provision of suitable energy substitutes.
After the immediate postoperative period, acute rejection has been shown in rats to decrease the redox poten:=aI of hepatic mitochondria (22) . The same thing was seen d:'Clatically in one of our recipients whose rejecting liver was ltSCUed with FK506. The patient who was unconscious with npidly developing hyperbilirubinemia and declining AKBR hid reversal of all these parameters within a short time after substituting FK506 for cyclosporine.
Recent studies in Pittsburgh have demonstrateci I correlation of high endotoxin levels pre-and postoperati\'ely and during the an hepatic period with graft failure and a ~ mortality (23, 24) . Related studies in Kyoto have shoWl: that severe endotoxemia typically occurs after the decrease is the AKBR in patients undergoing partial hepatectomy (25) . :\ decrease in the AKBR may be the basic cause leading to mdtiple organ failure (3. 4) . A marked decreased in the AKBR ro:ld be a case of endotoxemia and graft failure, or alternatively rouId be the consequence of endotoxemia. The interaction of ~ factors will be important to clarify in future research.
ORAL DISCUSSION DR. BUSUTTIL (Los Angeles, California); As you know, we are looking at KBR at UCLA, and our results with adults are very similar to what you have shown. However, in a group of children which we have studied, we found that they are much more forgiving. They can have a lower KBR for a longer period of time and still show evidence of very nice graft function. Do yOU have an explanation for that? DR. ASONUMA: I have no data for the children, so I can't say anything, but there might be some difference between the children and adults. In adults we think the State 3 KBR at 24 hr or at 48 hr is very critical.
DR. GORDON (Pittsburgh, Pennsylvania); Have you studied at all patients who are taking FK with the KBR? FK has interesting effects on the liver that far exceed those of cyclosporine, such as the hepatotrophic effect. Is there any difference in these ratios in patients taking FK versus cyclosporine? DR. ASONUMA: Both of these patients are FK patients and you can see the results. The graft failure is less than the previous reports of the cyclosporine. We tried to compare the cyclosporine patients and the FK patients in the changes of the AKBR, but we cannot find that here in this study.
DR. BOLLINGER (Duke University): Can I ask, Dr. Asonuma, how you are using this indicator at Pittsburgh right now? DR. ASONUMA: We're trying to do a preliminary study to the routine examination, but the system is not yet established.
